| Hans-Günter Meyer-Thompson | Verschiedene
Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
Cai M, Choi T, Xie Y, Al-Aly Z.
BMJ 2026; 392 :e086886 doi:10.1136/bmj-2025-086886